• DOI:10.3111/13696998.2013.873723
Corpus ID: 9484506

Recent trends in brand-name and generic drug competition

@article{Grabowski2014RecentTI,
  title={Recent trends in brand-name and generic drug competition},
  author={H. Grabowski and Genia Long and R. Mortimer},
  journal={Journal of Medical Economics},
  year={2014},
  volume={17},
  pages={207 - 214}
}

H. Grabowski, Genia Long, R. Mortimer

Published 2014

Medicine, Business

Journal of Medical Economics

OBJECTIVE To provide evidence on recent trends in: (1) market exclusivity periods (MEPs, the time between launch of a brand-name drug and its first generic competitor) for new molecular entities (NMEs); (2) the likelihood and timing of patent challenges under Paragraph IV of the Hatch-Waxman Act; and (3) generic drug penetration. [...] Key MethodMETHODS IMS Health National Sales Perspectives data were used to calculate MEPs for the 257 NMEs experiencing initial generic entry between January 1995 and…Expand Abstract

View on Taylor & Francis

dukespace.lib.duke.edu

Save to Library

Create Alert

Cite

Launch Research Feed